{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:53:59Z","timestamp":1782842039299,"version":"3.54.5"},"reference-count":88,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>e-Prescribing is designed to assist in facilitating safe and appropriate prescriptions for patients. Currently, it is unknown to what extent e-prescribing for opioids influences experiences and outcomes. To address this gap, a rapid scoping review was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This rapid scoping review aims to (1) explore how e-prescribing has been used clinically; (2) examine the effects of e-prescribing on clinical outcomes, the patient or clinician experience, service delivery, and policy; and (3) identify current gaps in the present literature to inform future studies and recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A rapid scoping review was conducted following the guidance of the JBI 2020 scoping review methodology and the World Health Organization guide to rapid reviews. A comprehensive literature search was completed by an expert librarian from inception until November 16, 2022. Three databases were electronically searched: MEDLINE (Ovid), Embase (Ovid), and Scopus (Elsevier). The search criteria were as follows: (1) e-prescribing programs targeted to the use or misuse of opioids, including those that were complemented or accompanied by clinically focused initiatives, and (2) a primary research study of experimental, quasi-experimental, observational, qualitative, or mixed methods design. An additional criterion of an ambulatory component of e-prescribing (eg, e-prescribing occurred upon discharge from acute care) was added at the full-text stage. No language limitations or filters were applied. All articles were double screened by trained reviewers. Gray literature was manually searched by a single reviewer. Data were synthesized using a descriptive approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Upon completing screening, 34 articles met the inclusion criteria: 32 (94%) peer-reviewed studies and 2 (6%) gray literature documents (1 thesis study and 1 report). All 33 studies had a quantitative component, with most highlighting e-prescribing from acute care settings to community settings (n=12, 36%). Only 1 (3%) of the 34 articles provided evidence on e-prescribing in a primary care setting. Minimal prescriber, pharmacist, and clinical population characteristics were reported. The main outcomes identified were related to opioid prescribing rates, alerts (eg, adverse drug events and drug-drug interactions), the quantity and duration of opioid prescriptions, the adoption of e-prescribing technology, attitudes toward e-prescribing, and potential challenges with the implementation of e-prescribing into clinical practice. e-Prescribing, including key features such as alerts and dose order sets, may reduce prescribing errors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This rapid scoping review highlights initial promising results with e-prescribing and opioid therapy management. It is important that future work explores the experience of prescribers, pharmacists, and patients using e-prescribing for opioid therapy management with an emphasis on prescribers in the community and primary care. Developing a common set of quality indicators for e-prescribing of opioids will help build a stronger evidence base. Understanding implementation considerations will be of importance as the technology is integrated into clinical practice and health systems.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/49173","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T13:23:44Z","timestamp":1698845024000},"page":"e49173","source":"Crossref","is-referenced-by-count":1,"title":["Experiences and Outcomes of Using e-Prescribing for Opioids: Rapid Scoping Review"],"prefix":"10.2196","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9552-9139","authenticated-orcid":false,"given":"Sara J T","family":"Guilcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-5520","authenticated-orcid":false,"given":"Stephanie R","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1911-6129","authenticated-orcid":false,"given":"Mina","family":"Tadrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9087-1077","authenticated-orcid":false,"given":"Lisa M","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6011-4104","authenticated-orcid":false,"given":"Jessica","family":"Riad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4114-8971","authenticated-orcid":false,"given":"Andrea C","family":"Tricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4851-4380","authenticated-orcid":false,"given":"Simon","family":"Hagens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8942-6211","authenticated-orcid":false,"given":"Jennifer","family":"Lien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-3585","authenticated-orcid":false,"given":"Sukirtha","family":"Tharmalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-1965","authenticated-orcid":false,"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-020-00308-z"},{"key":"ref2","unstructured":"Federal Provincial and Territorial Special Advisory Committee on the Epidemic of Opioid OverdosesOpioid- and stimulant-related harms in CanadaPublic Health Agency of Canada2023-11-18https:\/\/health-infobase.canada.ca\/substance-re lated-harms\/opioids-stimulants"},{"key":"ref3","unstructured":"Opioid data analysis and resources United StatesU.S. Centers for Disease Control and Prevention20222023-11-18https:\/\/www.cdc.gov\/opioids\/data\/analysis-resources.html"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/add.12551"},{"key":"ref5","unstructured":"Opioid-related harms in CanadaCanadian Institute for Health Information2023-12-05https:\/\/www.cihi.ca\/sites\/default\/files\/document\/opioid-related-harms-report-2018-en-web.pdf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-022-00929-y"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-022-00970-x"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12927\/hcq.2019.26025"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsurg.2017.06.020"},{"key":"ref10","unstructured":"HattLThe opioid crisis in CanadaLibrary of Parliament202201062023-11-18https:\/\/lop.parl.ca\/staticfiles\/PublicWebsite\/Home\/ResearchPublications\/HillStudies\/PDF\/2021-23-E.pdf"},{"key":"ref11","unstructured":"FriesenELKurdyakPAGomesTKollaGLeecePZhuLToombsEO'NeillBStallNMJuniPMushquashCJMahLThe impact of the COVID-19 pandemic on opioid-related harm in OntarioOntario COVID-19 Science Advisory Table20212023-11-18https:\/\/covid19-sciencetable.ca\/sciencebrief\/the-impact-of-the-covid-19-pandemic-on-opioid-related-harm-in-ontario\/#:~:text=Rates%20of%20opioid%2Drelated%20 harm,the%20effectiveness%20of%20these%20interventions"},{"key":"ref12","unstructured":"Interactive opioid tool: opioid-related morbidity and mortality in OntarioPublic Health Ontario2023-11-18https:\/\/www.public healthontario.ca\/Data%20and%20Analysis\/Substance%20Use\/Interactive%20Opioid%20Tool"},{"key":"ref13","unstructured":"Pan-Canadian trends in the prescribing of opioids and benzodiazepines, 2012-2017Canadian Institute for Health Information20182023-11-18https:\/\/www.cihi.ca\/sites\/default\/files\/document\/opioid-prescribing-june2018-en-web.pdf"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170363"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"ref16","unstructured":"e-prescribing joint statementCanadian Medical Association & Canadian Pharmacists Association20122023-11-18https:\/\/www.pharmacists.ca\/cpha-ca\/assets\/File\/ePrescribingStatementENG2013.pdf"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1460458217720396"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000684"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jppr.1243"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-009-1238-8"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2011-000205"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1331\/japha.2009.08013"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2011.01249.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2017.03.009"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3109\/17538157.2014.948170"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2015.03.001"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.3491"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.05.028"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000247"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2017.10.003"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7326\/M13-1705"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2015.11.005"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000163641.86870.af"},{"key":"ref34","author":"Peters, MD","year":"2020","journal-title":"JBI Manual for Evidence Synthesis"},{"key":"ref35","unstructured":"TriccoACLangloisEVStrausSEOrganizationWHRapid reviews to strengthen health policy and systems: a practical guideWorld Health Organization20172023-11-18https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/258698\/9789241512763-eng.pdf"},{"key":"ref36","unstructured":"GarrittyCGartlehnerGNussbaumer-StreitBKingVJHamelCKamelCAffengruberLStevensACochrane rapid reviews: interim guidance from the Cochrane rapid reviews methods groupCochrane Rapid Reviews Methods Group20202023-11-18https:\/\/methods.cochrane.org\/sites\/methods.cochrane.org.rapidreviews\/files\/uploads\/cochrane_rr_-_guidance-23mar2020-final.pdf"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"ref38","unstructured":"GuilcherSMcCarthyLTadrousMGomesTCiminoSRMahajanSE-prescribing and opioid misuse rapid review: a scoping review protocolOpen Science Framework202211162023-12-08https:\/\/osf.io\/9zpcg\/"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2015.11.008"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-019-2619-8"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05236-8"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.01.021"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3163\/1536-5050.104.3.014"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2004.028662"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2165\/11538310-000000000-00000"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06276-1"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2017.0367"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.2083"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2019.03.052"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/s1130-6343(05)73670-9"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.27951"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000001081"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2011-000124"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2017-006597"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-021-01717-8"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-001487"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2022.08.009"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-017-0489-z"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.07.015"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2072"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.07.043"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-012-9642-2"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2019.01.010"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.05.019"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2017.10.33798"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/1742-6723.13192"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsg.2021.12.001"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13136"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.2196\/24360"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2012-001499"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2011-000209"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-014-9976-z"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-022-01779-9"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.252"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1177\/1078155213487395"},{"key":"ref76","unstructured":"Mandatory electronic prescribing of controlled substances (EPCS) can help combat the opioid crisis and save the united states up to $53 billion annuallyVisante Point of Care Partners20182023-11-18https:\/\/www.pcmanet.org\/wp-content\/uploads\/2018\/04\/Savings-from-Mandatory-Use-of-EPCS-FINAL-1.pdf"},{"key":"ref77","author":"Ariosto, DA","year":"2011","journal-title":"Factors Leading to False Positive Computerized Provider Order Entry (CPOE) Opiate Allergy Alerts"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.9191"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.16726"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.26523"},{"issue":"9","key":"ref81","first-page":"612","volume":"65","author":"Clarke, H","year":"2019","journal-title":"Can Fam Physician"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-019-0947-2"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2413"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.24095\/hpcdp.41.6.03"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-4-50"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1136\/ebnurs-2022-103608"},{"key":"ref87","unstructured":"Opioid prescribing for acute pain: care for people 15 years of age and olderHealth Quality Ontario20182023-11-18https:\/\/www.hqontario.ca\/portals\/0\/documents\/evidence\/quality-standards\/qs-opioid-acute-pain-clinician-guide-en.pdf"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1177\/1715163518754918"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2023\/1\/e49173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:30:34Z","timestamp":1782840634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2023\/1\/e49173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":88,"URL":"https:\/\/doi.org\/10.2196\/49173","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.49173","asserted-by":"object"}]},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]}}}